DNAprint Genomics (DNAG)

[bendriver]

Where's OVANOME?


“If we had an effective early detection tool that would allow us to routinely diagnose ovarian cancer at its earliest stage, stage I, we would expect survival for this disease to be 85 to 95 percent — in the same range as for other stage I cancers,” Leiserowitz said. “It is imperative that we develop an early detection tool for this disease.”